Delivery Order SPE2DB22D1103-SPE2DB24FTRV4

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $51,462.68 firm fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of ENBREL 50 MG/ML SURECLICK syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a completion date...
The U.S. Defense Logistics Agency (DLA) awarded a $30,084.55 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers...
The U.S. Defense Logistics Agency (DLA) awarded a $12,601.23 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation (Corporate Office Division) to provide ENBREL 50 MG/ML SURECLICKML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment...
The Defense Logistics Agency (DLA) awarded a $9,482.29 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENBREL 50 MG/ML SURECLICK medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $100,466.56 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 MG/ML SURECLICK, a specialty medication, with a period of performance through September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceuticals. The $12,601.23 contract has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential...
This is a $9,663.06 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 MG/ML SURECLICK medical supplies and has a completion date of January 30, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. The $24,931.02 contract has an ultimate completion date of April 30, 2025. This delivery order is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,394.37 contract is for the supply of ENBREL 50 MG/ML SURECLICK medical supplies, with a period of performance through March 5, 2024. AmerisourceBergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $28,649.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564931859 ENBREL 50 MG/ML SURECLICK medication. The award, which has a completion date of June 18, 2024, is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRV4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $9,897.94 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of ENBREL 50 MG/ML SURECLICKML pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by September 24, 2024.

Generated 12/23/24, 2:27 PM